Monitor your assay’s performance and avoid the possibility of false positives and negatives with characterized controls at precise allelic frequencies. Horizon’s Reference Standards are derived from cell lines, for the closest representation of patient samples. Available in a wide range of formats including cfDNA, gDNA, FFPE, RNA fusions and formalin-compromised DNA. Horizon also offer a Custom Reference Standard service, partnering with you to produce the best controls for your assay.
Company Info:
Horizon Discovery Group plc (LSE: HZD) (“Horizon”), is a world-leading gene editing company that designs and engineers genetically-modified cells and then applies them in research and clinical applications that advance human health. Horizon’s core capabilities are built around its proprietary translational genomics platform, a highly precise and flexible suite of gene editing tools (rAAV, ZFN and CRISPR) able to alter almost any gene sequence in human or mammalian cell-lines. Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange’s AIM market under the ticker “HZD”.
Contact Information:
Horizon Discovery Ltd. 8100 Cambridge Research Park, Waterbeach, Cambridge CB25 9TL
Phone: +44 (0) 1223 976000
Email: info@horizondiscovery.com
